Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-01

Clinical Trial Update: New Clinical End-points in Patients With Primary Sjögren's Syndrome [Phase 2]

View source ↗

Summary

This Phase 2 trial update describes new clinical endpoints being assessed in patients with Primary Sjögren's Syndrome. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Primary Sjögren's Syndrome (pSS) | Phase 2 | Status: RECRUITING